Annotation Detail
Information
- Associated Genes
- FGF13
- Associated Variants
-
FGFR2 p.Pro253Arg (p.P253R)
(
ENST00000369059.5,
ENST00000346997.6,
ENST00000351936.11,
ENST00000356226.8,
ENST00000357555.9,
ENST00000358487.10,
ENST00000360144.7,
ENST00000369060.8,
ENST00000369061.8,
ENST00000457416.7,
ENST00000478859.5,
ENST00000369056.5,
ENST00000613048.4,
ENST00000638709.2,
ENST00000682550.1,
ENST00000682772.1,
ENST00000683211.1,
ENST00000684153.1 )
FGFR2 p.Pro253Arg (p.P253R) ( ENST00000346997.6, ENST00000351936.11, ENST00000356226.8, ENST00000357555.9, ENST00000358487.10, ENST00000360144.7, ENST00000369056.5, ENST00000369059.5, ENST00000369060.8, ENST00000369061.8, ENST00000457416.7, ENST00000478859.5, ENST00000613048.4, ENST00000638709.2, ENST00000682550.1, ENST00000682772.1, ENST00000683211.1, ENST00000684153.1 ) - Associated Disease
- Apert syndrome
- Source Database
- DisGeNET
- Description
- The crystal structure, of Pro252Arg FGFR1c in complex with FGF2, demonstrates that the enhanced ligand binding is due to an additional set of receptor-ligand hydrogen bonds, similar to those gain-of-function interactions that occur in the Apert syndrome Pro253Arg FGFR2c-FGF2 crystal structure.
- Pubmed
- 14613973
- Original source reporting the Gene Disease association
- BeFree
- DisGENET score for the Gene Disease association
- 0.00081432561624091
- Year of publication
- 2004
Drugs